Serum levels of sRAGE are positively correlated with the inflammatory markers tumor necrosis factor-α (TNF-α) and Monocyte Chemoattractant Protein-1 (MCP-1) in type 2 diabetic patients, making sRAGE a potential biomarker of inflammation [58]. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.